Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer

W.S. Hsieh, R. Soo, B.K. Peh, T. Loh, D.F. Dong, D. Soh, L.S. Wong, S. Green, J. Chiao, C.Y. Cui, Y.F. Lai, S.C. Lee, B. Mow, R. Soong, Manuel Salto-Tellez, B.C. Goh

Research output: Contribution to conferencePaper

56 Citations (Scopus)
Original languageEnglish
Pages1435-1442
Number of pages8
DOIs
Publication statusPublished - Nov 2009
Event18th AACR/EORTC/NCI International Conference on Molecular Targets and Cancer Therapeutics - Prague, Czech Republic
Duration: 01 Nov 200901 Nov 2009

Conference

Conference18th AACR/EORTC/NCI International Conference on Molecular Targets and Cancer Therapeutics
CountryCzech Republic
CityPrague
Period01/11/200901/11/2009

Cite this

Hsieh, W. S., Soo, R., Peh, B. K., Loh, T., Dong, D. F., Soh, D., Wong, L. S., Green, S., Chiao, J., Cui, C. Y., Lai, Y. F., Lee, S. C., Mow, B., Soong, R., Salto-Tellez, M., & Goh, B. C. (2009). Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer. 1435-1442. Paper presented at 18th AACR/EORTC/NCI International Conference on Molecular Targets and Cancer Therapeutics, Prague, Czech Republic. https://doi.org/10.1158/1078-0432.CCR-08-1748